These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22509402)

  • 1. Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.
    Marteau TM; Aveyard P; Munafò MR; Prevost AT; Hollands GJ; Armstrong D; Sutton S; Hill C; Johnstone E; Kinmonth AL
    PLoS One; 2012; 7(4):e35249. PubMed ID: 22509402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.
    Marteau TM; Munafò MR; Aveyard P; Hill C; Whitwell S; Willis TA; Crockett RA; Hollands GJ; Johnstone EC; Wright AJ; Prevost AT; Armstrong D; Sutton S; Kinmonth AL
    BMC Public Health; 2010 Nov; 10():680. PubMed ID: 21062464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the impact of pharmacogenomic prescribing on adherence to nicotine replacement therapy: A qualitative study of participants from a randomized controlled trial.
    Wright AJ; Sutton S; Armstrong D; Aveyard P; Kinmonth AL; Marteau TM
    Transl Behav Med; 2018 Jan; 8(1):18-28. PubMed ID: 29385578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.
    Lindson N; Chepkin SC; Ye W; Fanshawe TR; Bullen C; Hartmann-Boyce J
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD013308. PubMed ID: 30997928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
    Rose JE; Behm FM; Drgon T; Johnson C; Uhl GR
    Mol Med; 2010; 16(7-8):247-53. PubMed ID: 20379614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine replacement therapy for smoking cessation.
    Stead LF; Perera R; Bullen C; Mant D; Hartmann-Boyce J; Cahill K; Lancaster T
    Cochrane Database Syst Rev; 2012 Nov; 11():CD000146. PubMed ID: 23152200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine replacement therapy versus control for smoking cessation.
    Hartmann-Boyce J; Chepkin SC; Ye W; Bullen C; Lancaster T
    Cochrane Database Syst Rev; 2018 May; 5(5):CD000146. PubMed ID: 29852054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of a Nicotine Replacement Therapy Sample at Outdoor Smoking Hotspots for Promoting Quit Attempts: A Pilot Randomized Controlled Trial.
    Cheung YTD; Cheung Li WH; Wang MP; Lam TH
    Nicotine Tob Res; 2020 Aug; 22(9):1468-1475. PubMed ID: 31404466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive nicotine patch dosing prior to quitting smoking: feasibility, safety and effects during the pre-quit and post-quit periods.
    Przulj D; Wehbe L; McRobbie H; Hajek P
    Addiction; 2019 Mar; 114(3):515-522. PubMed ID: 30370685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Varenicline and Nicotine Replacement Therapy for Smoking Cessation in Older and Younger Smokers: A Prospective Cohort in Taiwan.
    Chang PY; Shiu MN; Yuan YT; Chang HC; Su PY; Lan TH
    Nicotine Tob Res; 2019 Jan; 21(2):149-155. PubMed ID: 29294121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.
    Schuit E; Panagiotou OA; Munafò MR; Bennett DA; Bergen AW; David SP
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011823. PubMed ID: 28884473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quitting Failure and Success With and Without Using Medication: Latent Classes of Abstinence and Adherence to Nicotine Monotherapy, Combination Therapy, and Varenicline.
    McCarthy DE; Versella MV
    Nicotine Tob Res; 2019 Oct; 21(11):1488-1495. PubMed ID: 30107419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the mu-opioid receptor gene with smoking cessation.
    Munafò MR; Elliot KM; Murphy MF; Walton RT; Johnstone EC
    Pharmacogenomics J; 2007 Oct; 7(5):353-61. PubMed ID: 17224915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine replacement therapy for smoking cessation.
    Stead LF; Perera R; Bullen C; Mant D; Lancaster T
    Cochrane Database Syst Rev; 2008 Jan; (1):CD000146. PubMed ID: 18253970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nicotine replacement therapy on quitting by young adults in a trial comparing cessation services.
    Buller DB; Halperin A; Severson HH; Borland R; Slater MD; Bettinghaus EP; Tinkelman D; Cutter GR; Woodall WG
    J Public Health Manag Pract; 2014; 20(2):E7-E15. PubMed ID: 24458316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial.
    Ray R; Jepson C; Wileyto EP; Dahl JP; Patterson F; Rukstalis M; Pinto A; Berrettini W; Lerman C
    Nicotine Tob Res; 2007 Nov; 9(11):1237-41. PubMed ID: 17978999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers.
    Thomas D; Abramson MJ; Bonevski B; Taylor S; Poole SG; Weeks GR; Dooley MJ; George J
    BMJ Open; 2015 Apr; 5(4):e006959. PubMed ID: 25888475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to increase adherence to medications for tobacco dependence.
    Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.